Blarcamesine: An Investigational Oral Drug for Alzheimer Disease

Update: 2025-01-25

Description

Timo Grimmer, MD, Associate Professor of Psychiatry and Psychotherapy and Head of the Centre for Cognitive Disorders at the Technical University of Munich, Germany, discusses the experimental oral small molecule drug blarcamesine, which is under investigation as a potential treatment for Alzheimer disease.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Comments

In Channel

Beyond Slowing Cognitive Decline: Patient and Caregiver Perspectives on Alzheimer’s Treatment

2025-09-0921:26

Beyond the Boardroom: Barbara Corcoran on Caregiving and Alzheimer Disease

2025-05-0117:42

Plasma P-Tau217: Detecting Alzheimer Disease with a Blood Test

2025-03-2120:59

Updated Criteria for Diagnosis and Staging of Alzheimer Disease: Recommendations of the International Working Group

2025-02-2511:31

Blarcamesine: An Investigational Oral Drug for Alzheimer Disease

2025-01-2516:27

The CMS GUIDE Model To Support Patients with Dementia and Their Caregivers

2024-12-1910:42

The BenfoTeam Clinical Trial: Investigating Benfotiamine as a Potential Therapy for Early Alzheimer Disease

2024-11-1915:41

BrainCheck as a Digital Cognitive Assessment Tool

2024-11-0807:17

Kramer, Van Dyck

2024-09-2712:18

CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 3

2024-09-2110:14

CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 2

2024-09-2117:02

CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 1

2024-09-2108:53

Labcorp's Biomarker Testing for Alzheimer Disease

2024-09-1612:50

What Neurologists Should Know About End-of-Life Care Discussions

2024-07-1920:47

Insights into the Role of Tau in Alzheimer Disease and Neurodegenerative Disorders

2024-07-1522:07

Strategies to Limit ARIA Associated with Alzheimer Disease Treatment

2024-07-1509:22

Real-World Implications Beyond Cognition in Treating Alzheimer Disease Patients with Donanemab

2024-07-1508:51

Emerging Therapeutic Targets for Alzheimer Disease

2024-07-1514:27

Progress in Diagnosis and Management of Neuropsychiatric Symptoms in People Living with Dementia

2024-07-0713:05

How Healthcare Providers Can Partner with Caregivers of People Living with Dementia

2024-07-0718:10

00:00

Blarcamesine: An Investigational Oral Drug for Alzheimer Disease

#box-pro-ellipsis-17576186080152{-webkit-line-clamp:2;}Blarcamesine: An Investigational Oral Drug for Alzheimer Disease

Blarcamesine: An Investigational Oral Drug for Alzheimer Disease

Practical Neurology

Blarcamesine: An Investigational Oral Drug for Alzheimer Disease